In this Australian Finance Podcast episode, Owen Rask is joined by Ryan Newman, Director of Research at The Motley Fool Australia, to discuss three ASX companies with exciting growth potential. They explore:
- How Ryan finds great companies
- What makes ResMed a global health leader
- Why GenTrack is disrupting utilities and airports
- How Pinnacle structures its boutique funds for success
If you enjoyed this chat about ASX growth shares, be sure to subscribe on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts for weekly investing insights!
Topics Covered
- Why Ryan Newman loves stock investing
- Mistakes and successes from Ryan’s investing journey
- How to research companies like a pro
- ResMed (ASX: RMD): Sleep apnea and health megatrends
- GenTrack (ASX: GTK): Software for utilities and airports
- Pinnacle Investment (ASX: PNI): Income from boutique fund ownership
- What to look for in a long-term growth business
- How optionality and business model strength play into returns
- Why patience and understanding your thesis are key
